Cargando…
Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma
Malignant melanoma is one of the most aggressive types of tumor. Because malignant melanoma is difficult to treat once it has metastasized, early detection and treatment are essential. The search for reliable biomarkers of early-stage melanoma, therefore, has received much attention. By using a nove...
Autores principales: | Shimbo, Takashi, Tanemura, Atsushi, Yamazaki, Takehiko, Tamai, Katsuto, Katayama, Ichiro, Kaneda, Yasufumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866734/ https://www.ncbi.nlm.nih.gov/pubmed/20479946 http://dx.doi.org/10.1371/journal.pone.0010566 |
Ejemplares similares
-
Cut-C: cleavage under tethered nuclease for conformational capture
por: Shimbo, Takashi, et al.
Publicado: (2019) -
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma
por: Kiyohara, Eiji, et al.
Publicado: (2022) -
Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins
por: Ho, Yen-Ting, et al.
Publicado: (2018) -
BPAG1n4 is essential for retrograde axonal transport in sensory neurons
por: Liu, Jia-Jia, et al.
Publicado: (2003) -
Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrow
por: Aikawa, Eriko, et al.
Publicado: (2015)